C aveolae are flask-shaped invaginations of the plasma membrane that are abundant features of smooth muscle. Following their initial description in epithelial cells almost 50 years ago (15) many diverse functional roles have been ascribed to caveolae, including regulation of macromolecular transport, particularly cholesterol deposition, cell volume regulation, and Ca 2+ homeostasis. The discovery in the early 1990s of caveolins, a family of proteins critical to caveolar formation that, in vitro, interact with a variety of signal-transducing molecules, has highlighted an additional possible function of caveolae: as sites of integration of events linking extracellular stimuli and intracellular effectors. In addition to altering [Ca 2+ ] i , receptor-coupled activation of smooth muscle contractility involves a sensitization of the myofilaments to the activating Ca 2+ (11). The primary mechanism of force generation is the Ca 2+ -and calmodulindependent phosphorylation of the regulatory myosin light chains (MLC 20 ) by MLC kinase. MLC 20 dephosphorylation by MLC phosphatase precedes relaxation, and both the kinase and phosphatase are under regulatory influences. RhoA and protein kinase C (PKC)-α, two intracellular proteins acting downstream of receptor activation, have been proposed to be important mediators of smooth muscle contractility. Both molecules have been suggested to sensitize the contractile filaments to Ca 2+ by separate upstream mechanisms, which, however, converge downstream by inhibiting MLC phosphatase activity (thereby increasing MLC 20 phosphorylation and force). The effects of rhoA appear to be mediated in large part via activation of the effector molecule rho-associated kinase (ROK). Recently, with the use of immunofluorescent laser scanning confocal microscopy and subsequent digital image analysis, we quantified the distributions of rhoA, ROK, and PKC-α in isolated, intact, contractile smooth muscle cells. Agonist stimulation resulted in significant redistribution of all three molecules from the cytoplasm to the cell periphery (12). These results were consistent with the suggestions that membranous relocalization of rhoA and PKC-α was a necessary step for receptor-induced Ca 2+ sensitization of force. Furthermore, receptor-coupled Ca 2+ -sensitization occurred in these cells without significant redistribution of ROK away from the membrane (12). An intriguing possibility, therefore, was that caveolae may be involved in the stimulus-dependent alterations of smooth Cell 98: 377-386, 1999. 9. McNew JA, Parlati F, Fukuda R, Johnston RJ, Paz K, Paumet F, Sollner TH, and Rothman JE. 
Smooth muscle contractile regulation
A stimulus-induced increase in the concentration of intracellular Ca 2+ ([Ca 2+ ] i ) is the prime modulator of smooth muscle contractility. The major source of this [Ca 2+ ] i elevation arises from transsarcolemmal Ca 2+ influx, but the sarcoplasmic reticulum (SR) is also a prominent intracellular store of releasable Ca 2+ used for smooth muscle contractile activation. The Ca 2+ released from the SR [via inositol 1,4,5-trisphosphate (IP 3 )-induced Ca 2+ release and/or via transsarcolemmal Ca 2+ -induced Ca 2+ release] can either directly activate the contractile filaments or indirectly alter the excitability of the cell by affecting ion channel activity in the plasma membrane.
In addition to altering [Ca 2+ ] i , receptor-coupled activation of smooth muscle contractility involves a sensitization of the myofilaments to the activating Ca 2+ (11) . The primary mechanism of force generation is the Ca 2+ -and calmodulindependent phosphorylation of the regulatory myosin light chains (MLC 20 ) by MLC kinase. MLC 20 dephosphorylation by MLC phosphatase precedes relaxation, and both the kinase and phosphatase are under regulatory influences. RhoA and protein kinase C (PKC)-α, two intracellular proteins acting downstream of receptor activation, have been proposed to be important mediators of smooth muscle contractility. Both molecules have been suggested to sensitize the contractile filaments to Ca 2+ by separate upstream mechanisms, which, however, converge downstream by inhibiting MLC phosphatase activity (thereby increasing MLC 20 phosphorylation and force). The effects of rhoA appear to be mediated in large part via activation of the effector molecule rho-associated kinase (ROK). Recently, with the use of immunofluorescent laser scanning confocal microscopy and subsequent digital image analysis, we quantified the distributions of rhoA, ROK, and PKC-α in isolated, intact, contractile smooth muscle cells. Agonist stimulation resulted in significant redistribution of all three molecules from the cytoplasm to the cell periphery (12) . These results were consistent with the suggestions that membranous relocalization of rhoA and PKC-α was a necessary step for receptor-induced Ca 2+ sensitization of force. Furthermore, receptor-coupled Ca 2+ -sensitization occurred in these cells without significant redistribution of ROK away from the membrane (12) . An intriguing possibility, therefore, was that caveolae may be involved in the stimulus-dependent alterations of smooth muscle [Ca 2+ ] i and the relocation of contractile regulatory signal-transducing molecules to the plasma membrane.
Caveolae morphology in smooth muscle
Caveolae are 50-to 90-nm flask-shaped invaginations that appear in rows in periodic register along the longitudinal axis of the smooth muscle membrane, interspersed by regions of dense bodies anchoring the cytoskeleton, as illustrated in Fig. 1A . Caveolae thus constitute a substantial proportion of the smooth muscle cell membrane, increasing the surface area by up to 75% (2, 10) . Developmental changes in smooth muscle caveolae are evident with increasing density throughout embryogenesis and adulthood up to ~35/µm 2 . Exogenous markers penetrate the caveolar invagination, indicating that the necks of caveolae can be in free contact with the extracellular space. Compared with other cell types, smooth muscle caveolae have thus been suggested to be relatively static structures. However, although usually appearing as singular invaginations, multiple caveolae can fuse to offer a tube-like appearance. Although caveolar density may not change in response to physiological levels of smooth muscle stretch (2) , it is still a matter of debate whether they act as sensors to stretch and/or volume changes via a widening of the neck region, leading to a more flattened appearance (7) . However, this does not appear to be the case with physiological hypertrophy (e.g., uterine smooth muscle of pregnant rat in Fig. 1A ) or experimental hypertrophy of smooth muscle cells, where caveolae assume a normal appearance.
Caveolin expression and localization in smooth muscle
In recent years the discovery of caveolins, a family of proteins forming the main structural component of caveolae, has witnessed an explosion of interest in the possible functional role(s) of caveolae in diverse cell types. Three main mammalian isoforms of caveolin exist (termed caveolin-1, -2, and -3; reviewed in Refs. 6 and 8) . Morphological analysis of a cultured cell line lacking caveolae, and not expressing caveolins, showed that transfection of caveolin-1 or -3 promoted the appearance of caveolar membranous invaginations. Homoand heterooligomeric complexes of caveolin, together with their interaction with membrane lipids, especially cholesterol, Caveolin localization in isolated smooth muscle. Single uterine smooth muscle cells isolated from pregnant rat were fixed, permeabilized, and stained for caveolin-1, -2, or -3 with isoform-specific antibodies. Laser scanning confocal microscopic analysis of central cell sections indicated that each caveolin isoform was predominantly located at the plasma membrane. Scale bar = 10 µm.
are thought to contribute to the morphological appearance of caveolae. Caveolin expression has been found in every smooth muscle so far tested, suggesting that each isoform may be ubiquitously expressed in smooth muscle (caveolin-3 expression is thought to be predominantly restricted to muscle tissue; see Ref. 13 ). Analysis of caveolin-1 and -3 immunostaining has additionally found both isoforms to be present throughout the arterial vasculature (9) . Also, in isolated smooth muscle cells, as observed in Fig. 2 , immunofluorescent confocal microscopy has indicated that each caveolin isoform assumes a predominantly plasma membranous distribution (13) . Notably, various disease states have resulted in changes in caveolin levels and/or appearance of caveolae: modification of cholesterol levels (e.g., hypercholesterolemia) results in alterations of caveolin expression, as well as caveolae morphology, and caveolin gene defects have been associated with muscular dystrophy.
Caveolae and smooth muscle [Ca

2+
] i homeostasis.
In many smooth muscles, as indicated for rat portal vein in Fig. 1B , caveolae are often, although not exclusively, in close proximity to the underlying network of peripheral SR. This may be of functional importance given the prominent role of the SR in [Ca 2+ ] i regulation mentioned above. Indeed, the peripheral SR, which can form a continuous tubular network with the nuclear membrane, often completely envelopes caveolae (Fig. 1B, inset ; see also Ref. 5) . Although surface couplings between the peripheral SR and the (noncaveolar) plasma membrane have been reported, with electron opaque material spanning the 10-to 20-nm gap between membranes (10), the SR does not appear to directly join to caveolae.
Mitochondria are often also observed in proximity to caveolae, and the SR can neatly encircle these organelles too (5) . Such close geometric relationships between caveolae and intracellular organelles such as the SR, mitochondria, and nucleus may be advantageous in allowing smooth muscle to tightly regulate [Ca 2+ ] i fluxes (see below), energy use, and gene expression.
Early electron microscopic studies of smooth muscle suggested that significant Ca 2+ deposition occurred in caveolae. In addition, freeze fracture investigations indicated a prominent clustering of intramembrane particles close to the neck of caveolae (2, 10), and striations on smooth muscle caveolae have also been reported (7, 10) . The subsequent use of different experimental methodologies, although a cautionary note should be made of the limitations of each, has led to the identification of several proteins likely to be resident in smooth muscle caveolae. Immunoelectron microscopy studies localized both a Ca 2+ -ATPase and an IP 3 -like receptor to smooth muscle caveolae (1) . Subcellular fractionation and immunoprecipitation data of cultured smooth muscle also suggests caveolar accumulation of receptors for contractile agents (e.g., bradykinin) linked to phosphoinositide hydrolysis (14) . Additionally, high resolution light microscopy data suggested that the Na + /Ca 2+ exchanger, the activity of which is closely influenced by SR-releasable Ca 2+ , may be enriched in caveolar regions of the smooth muscle membrane (4). As such, the residence of caveolae adjacent to the SR, commonly separated by distances as little as 10-40 nm, together with the caveolar localization of proteins important for Ca 2+ mobilization and transport, supports the notion that these plasmalemmal structures may be influential in the regulation of smooth muscle Ca 2+ homeostasis. It is noteworthy that, in constantly perfused cultured endothelial cells, agonist-induced (e.g., bradykinin) increases in [Ca 2+ ] i , originating from endoplasmic reticular Ca 2+ release, occurred at specific loci towards the cell periphery directly opposite plasma membranous areas rich in caveolin and, therefore, presumably containing caveolae (3). Given the reported increased intensity of caveolin staining at the cell extremities (13) , and of regions opposite the nucleus, it will be of great interest to establish whether such a phenomenon exists in smooth muscle.
In vitro interactions of caveolins and signal transduction molecules
Cell-free studies have indicated that caveolins interact with a variety of signal-transducing molecules and regulate their activity, including PKC-α, rhoA, Raf, mitogen-activated protein kinase, G α subunits, and receptor-dependent tyrosine kinases (reviewed in Refs. 6 and 8). A short NH 2 terminal cytoplasmic region of caveolin-1 (residues 82-101) was found to be critical for these regulatory interactions and was termed the "scaffolding domain." Analogous regions exist in caveolins-2 and -3. Indeed, the scaffolding domain of caveolin-3 has also been shown to regulate the activity of the catalytic domain of PKC-α.
Caveolin scaffolding domain and smooth muscle signaling proteins
As mentioned above, the caveolin-1 scaffolding domain is a region crucial for the regulatory interaction with diverse signal-transducing molecules in in vitro biochemical studies, including PKC-α and rhoA. Indeed, use of the caveolin-1 scaffolding domain to select peptide ligands from bacteriophage display libraries allowed the identification of amino acid motifs (ΨXΨXXXXΨ and ΨXXXXΨXXΨ, where Ψ = aromatic amino acid) characteristic of many signaling proteins suggested to interact with caveolins (6 ). In particular, the sites of monoglucosylation and ADP ribosylation of rhoA, modifications of functional importance because they result in inhibition of agonist-induced Ca 2+ sensitization and/or rhoA translocation, are contained within the putative caveolin-binding motif of rhoA. This sequence of rhoA is also contained within a region of the molecule thought to be important for interaction with ROK. In addition, the caveolin-1 scaffolding domain peptide assumes a homogeneous distribution throughout the cytoplasm when chemically loaded into single isolated smooth muscle cells. Under these circumstances, agonist-induced translocations of rhoA and PKC-α from the cytoplasm to the cell membrane are completely inhibited (see Fig. 3 ), an effect not observed in sham-treated cells or cells loaded with a scrambled peptide (13) . These results further support the notion that there is a direct interaction between the scaffolding domain region of caveolin(s) and rhoA and PKC-α in intact contractile smooth muscle. Although the influence of the scaffolding domain peptides of caveolins-2 and -3 on the activities of various signaling molecules has been examined in other cell types, their effects on membranous recruitment of rhoA and PKC-α in smooth muscle remains unresolved. The seemingly ubiquitous expression of each caveolin isoform in smooth muscle, and the consequent possibility (as yet undetermined) of caveolin-specific caveolae, may thus allow for a spatial selectivity of multiple signal transduction pathways.
Conclusions
Receptor-coupled stimulation of smooth muscle involves both an increase in [Ca 2+ ] i and plasma membranous recruitment of signaling molecules important for Ca 2+ sensitization of force production. Caveolar accumulation of many molecules associated with stimuli-induced [Ca 2+ ] i alterations, together with the close association of caveolae to the underlying peripheral SR, is suggestive of an important role for these membrane invaginations in smooth muscle Ca 2+ homeostasis (Fig. 4) . The inhibition of rhoA and PKC-α translocation by the caveolin scaffolding domain peptide in intact smooth muscle cells indicates that caveolins, and by implication caveolae, may be involved in the membranous recruitment of key signaling molecules acting downstream of receptor activation (Fig. 4) .
Caveolae, therefore, may be specialized plasmalemmal regions involved in the integration of extracellular contractile signals and intracellular effectors in smooth muscle. Such localized membranous coordination of signal-transducing events may offer an efficient mechanism for smooth muscle excitation-contraction coupling. releases of SR Ca 2+ . These functional changes were suggested to be due to an alteration in the structural arrangement of caveolae and the underlying SR. 
